氨·二甲胺·羧酸根合铂(Ⅱ)类配合物的合成、抗肿瘤活性和与DNA的键合水平

本工作设计合成了6种新型混胺羧酸根合铂(Ⅱ)类配合物[Pt((?)NH)(NH₃)X₂](a～f){其中，X=CH₃COO^-(乙酸根)，CH₃Cl COO^-(氯乙酸根)，CHCl₂COO^-(二氯乙酸根)，C₆H₅-COO^-(苯甲酸根)，p-CH₃-C₆H₄-COO^-(对甲基苯甲酸根)，p-CH₃O-C₆H₄-COO^-(对甲氧基苯甲酸根)}。通过元素分析、摩尔电导、差热分析、红外光谱、紫外光谱和 ¹H核磁共振谱对配合物进行了表征。通过MTT法研究了配合物的体外抗肿瘤活性，通过等离子体质谱研究了配合物与细胞DNA的键合量；体外抗肿瘤活性测试表明，配合物(a～f)对所测试的肿瘤细胞MCF-7、HCT-8和BGC-823没有表现出活性，但对EJ和HL-60两种肿瘤细胞表现出好的活性，而且配合物(d～f)对HL-60细胞的活性与顺铂相当。配合物(a～f)与HL-60细胞的DNA键合量与其作用浓度表现出一定的依赖性，从小到大的顺序为：cisplatin < c < b < a < f < e < d。     

氨·环己胺·羧酸根合铂(Ⅱ)类配合物的合成、抗肿瘤活性和与DNA的键合水平

本工作设计合成了6种新型氨·环己胺·羧酸根合铂(Ⅱ)类配合物[Pt(NH₃)((?)-NH₂)X₂](a～f){其中，X=CH₃COO^-(乙酸根)，CH₂ClCOO^-(氯乙酸根)，C₆H₅-COO^-(苯甲酸根)，p-CH₃O-C₆     

1R，3S-1，2，2-三甲基-1，3-环戊二胺为配体的铂(Ⅱ) 配合物的合成、表征和抗肿瘤活性

本文合成了9种含有由天然D(+)-樟脑衍生的1R，3S-1，2，2-三甲基-1，3-环戊二胺(A)为配体的铂(Ⅱ)配合物[Pt(Ⅱ)AX]{其中，X=(CH₂)₃C(COO^-)₂(1，1-环丁烷二羧酸根)，2CH₃OCH₂COO^-，2CH₃CH₂OCH₂COO^-，2CH₃(CH₂)₃OCH₂COO^-，[OCH(CH₃)COO]^2-(乳酸根)，(OCH₂COO)^2-(乙醇酸根)，2CH₃OCH₂CH₂OCH₂COO^-，2CH₃CH₂OCH₂CH₂OCH₂COO^-和2CH₃(CH₂)₃OCH₂CH₂OCH₂COO^-}。通过元素分析、热重分析、红外光谱、¹H核磁共振谱和电喷雾质谱等对配合物进行了表征。体外生物活性测试表明，部分配合物对A549人肺癌细胞和HCT-116人结肠癌细胞具有较强的抗肿瘤活性。     

酰腙类化合物的合成和阴离子识别研究

本文设计合成了3种新型的酰腙类受体分子。利用紫外-可见吸收光谱及 ¹H NMR考察了其与F^-、Cl^-、Br^-、I^-、CH₃COO^-、HSO₄^-、NO₃^-等阴离子的作用。结果表明，该类受体分子能较好地识别阴离子F^-和CH₃COO^-，在DMSO溶液中主客体之间形成氢键加合物。尤其对于受体3(间苯双对硝基苯氧乙酰腙)，加入F^-和CH₃COO^-时，溶液颜色有明显变化，受体3对这两种阴离子可实现裸眼识别。     

微波辐射固相法合成缩二脲铜配合物

The copper(Ⅱ) complexes of biuret have been synthesized by solid phase reaction with microwave irradiation. The compositions and structures of the complexes are characterized by elemental analysis, molar conductance, in-frared spectra, electronic spectra, magnetic susceptibility, thermogravimetric and differential thermal analysis, X-ray powder diffraction. The two complexes have the compositions of [Cu(bi)₂]Cl₂(A) and [Cu(bi)₂](NO₃)₂(B)(bi=NH₂CONHCONH₂) and the molecular formulae of CuC₄H₁₀O₄N₆Cl₂ and CuC₄H₁₀O₁₀N₈, respectively. The molar conductance data show that the complexes are 1∶2 electrolyte. Infrared spectra of the complexes show oxygen atoms have been coordinated with divalent copper ion. The thermal decomposition processes of the complexes show that the final residues are all cupper oxide. The results of indexes to the X-ray powder diffraction data indicate that the crystal structure of the complexes belong to monoclinic system, the lattice parameters are: a=0.6976nm,b=1.1546 nm,c=2.1689nm,β=96.80°,V=1.7346nm³ for A; and a=0.7096nm,b=1.1359 nm,c=2.1002 nm,β=97.05°,V=1.6800nm³ for B, respectively.     

基于二茂铁羧酸配体的镉配合物的合成及结构研究

以二茂铁甲酸根FcCOO^-(Fc=(η⁵-C₅H₅)Fe(η⁵-C₅H₄))为主要配体，合成了3个新的配合物[Na₂Cd( μ₃-η²-FcCOO^-)₂(μ₂-η²-FcCOO^-)₂(CH₃OH)₂]_n (1)、[Cd(phen)(FcCOO^-)(η²-FcCOO)(H₂O)](phen=邻菲咯啉) (2)、[Cd(Det)(η²-FcCOO^-)(FcCOO^-)](H₂O)₂(Det=二乙撑三胺) (3)。测定了配合物的晶体结构。配合物1为单斜晶系，C2/c空间群，二茂铁甲酸根采用μ₃-η²-FcCOO^-和μ₂-η²-FcCOO^-的配位方式将Cd²⁺和Na⁺连接成一维无限链状结构。配合物2和3均为单核结构，单斜晶系，P2₁/c空间群，二茂铁甲酸根都采用 FcCOO^-和η²-FcCOO^-的方式配位。2中phen以双齿螯合形式配位，水分子参与配位，中心镉离子配位数为6。3中Det以三齿螯合形式配位，中心镉离子配位数也为6，但水分子未参与配位。     

二茂铁羧酸及含氮配体构筑的锌(II)和镉(II)配合物的合成、晶体结构及电化学性质

使Zn(OAc)₂·2H₂O或Cd(OAc)₂·2H₂O与邻羧基苯甲酰二茂铁钠(o-OOCC₆H₄COFcNa；Fc=(η⁵-C₅H₅)Fe(η⁵-C₅H₄))和1，10-邻菲咯啉(phen)在甲醇中反应，合成了含有混合配体的单核配合物[Zn(o-OOCC₆H₄COFc)₂(phen)(H₂O)]·CH₃OH (1)和双核配合物{[Cd(η²-o-OOCC₆H₄COFc)( μ₂-o-OOCC₆H₄COFc)(phen)]·CH₃OH₂·H₂O}₂ (2)。晶体结构表明：在1中，单核的结构单元通过分子间氢键形成了一维的长链结构；在2中，o-FcCOC₆H₄COO^-以及phen均双齿螯合中心Cd(II)离子，随后在o-FcCOC₆H₄COO^-的双齿桥联下，形成一个双核结构。研究了这2个配合物在DMF溶液中的电化学性能。     

基于半夹心Cp*Rh单元的超分子桥环和螺环化合物的构筑策略

桥环和螺环化合物是有机化学中常用的概念而在其他领域鲜有提及。在本研究中,我们将桥环和螺环的概念拓展至超分子化学领域中并提出了相应的构筑策略。在刚性直线型配体中引入额外的螯合位点,通过配位驱动、分步组装的方法合成了复杂的3个有机金属超分子桥环化合物[(Cp*Rh)₆(μ-η²-η²-C₂O₄)₂(μ-C₂O₄)(L^A)₂](OTf)₆(1)、[(Cp*Rh)₆(dhbq)₂(pyrazine)(L^A)₂](OTf)₈(2)和[(Cp*Rh)₆(tpphz)₂(bpea)(L^A)₂](OTf)₁₂(3),以及一个超分子螺环化合物(Cp*Rh)₁₂(bibzim)₃Ru (L^A)₃(L^B)₃](OTf)₁₀(PF₆)₄(4),其中L^A=3,3′-di (pyridin-4-yl)-2,2′-bipyridine,OTf^-=CF₃SO^3-,dhbq=2,5-dihydroxy-1,4-benzoquinone,tpphz=tetrapyrido[3,2-a∶2′,3′-c∶3″,2″-h∶2'',3''-j]phenazine,bpea=1,2-di (pyridin-4-yl) ethane,bibzim=2,2′-bisbenzimidazole,L^B=4,4′-di (pyridin-4-yl)-1,1′-biphenyl。并通过单晶X射线衍射的方法一一表征了它们的单晶结构。     

含氟喹诺酮双核铜(Ⅱ)配合物的合成、晶体结构和生物活性

A new binuclear copper(Ⅱ) complex containing fluoroquinolone ligand， [Cu₂(cfc)₂(bpy)₂(pip)]·6H₂O， was synthesized and its crystal structure was solved. The formula of the complex is C₂₅H₂₆ClCuFN₄O₆， and the crystal-lography data are as follows， triclinic， space group P1， a=6.874(2)?， b=10.761(3)?， c=17.976(5)?， α=80.071(6)°， β=85.253(6)°， γ=79.109(6)°， V=1284.5(6)?3， D=1.542g·cm^-3， F(000)=614， and Z=2. R₁=0.0776 and wR₂=0.2235(I >2σ(I)). The copper atom is five-coordinate with square-based pyramidal geometry and involves two nitrogen atoms from bpy， two oxygen atoms from cfc and one nitrogen atom from pip anion. The stacking effect between cfc and bpy ligands from two neighboring molecules was observed. Both ligand and complex were assayed against gram-positive and gram-negative bacteria by doubling dilutions method， the complex shows the same minimal inhibitory concentration (MIC) as the corresponding ligand against S.Aureus and E.Coli bacteria. The inhibitory effect of the ligand and complex on leukemia HL-60 cell line and liver cancer BEL-7402 cell line have been measured by using MTT (Methyl-Thiazol- Tetrozolium) and SRB (Sulphurhodamin B) assay methods. The results indicated that the complex has strong inhibitory effect on HL-60 cell line and on BEL-7402 cell line. CCDC： 191087.     

DACO-CuⅡ-SCN-三元配合物的合成、表征及结构研究（DACO=1，5-二氮环辛烷）

A new mononuclear Cu^Ⅱ complex of DACO [Cu(DACO)₂(SCN)]·(SCN)·2H₂O (1) was prepared by introducing a co-ligand SCN^- anion. The crystal structure of 1 was determined by X-ray diffraction analysis. The crystallographic data are: monoclinic, P2₁/n, a=0.728 5(4) nm, b=2.479 0(15) nm, c=1.069 7(6) nm, β=93.861(10)°, V=1.927(2) nm³, Z=4. The Cu^Ⅱ atom takes the square-pyramidal coordination geometry. The SCN^- anions adopt both monodentate coordination and uncoordinated forms in the crystal. The coordinated cation, SCN^- counter anion and the lattice water molecules are further linked through hydrogen bonds to form a one-dimensional chain motif. The spectral and thermal properties of 1 were studied. CCDC: 243104.